STORY FROM: Drugs & Medical Devices
Biomet M2a Hip Action to Proceed to Trial in Ga. Federal Court
July 29, 2020
MACON, Ga. — A Georgia federal judge has allowed a Biomet hip replacement action to proceed to trial on theories of failure to warn, design defect, and negligence, ruling that the plaintiff has adequately proved causation via expert testimony.
In a July 27 order, Judge Tilman E. Self III of the U.S. District Court for the Middle District of Georgia further held that the plaintiff presented admissible expert testimony that Biomet did not adequately communicate the device warnings to the implanting surgeon.
Lynwood Hardison received an M2a Magnum hip implant on Feb. 4, 2009, when he was 56. In 2014, ...
Associated Law Firms
Beasley Allen Crow Methvin Portis & Miles
Clark & Smith
Faegre Drinker Biddle & Reath
LaDue Curran & Kuehn
Troutman Sanders LLP